Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Capital Employed (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Return on Capital Employed data on record, last reported at 0.44% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 410.0% year-over-year to 0.44%; the TTM value through Dec 2025 reached 0.44%, up 410.0%, while the annual FY2025 figure was 0.36%, 134.0% up from the prior year.
  • Return on Capital Employed reached 0.44% in Q4 2025 per VRCA's latest filing, up from 1.48% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.39% in Q1 2023 and bottomed at 4.54% in Q4 2024.
  • Average Return on Capital Employed over 5 years is 1.59%, with a median of 1.24% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: crashed -363bps in 2024, then skyrocketed 410bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.81% in 2021, then skyrocketed by 39bps to 0.49% in 2022, then plummeted by -86bps to 0.91% in 2023, then tumbled by -400bps to 4.54% in 2024, then soared by 90bps to 0.44% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.44% in Q4 2025, 1.48% in Q3 2025, and 3.39% in Q2 2025.